Tenet Q2 adjusted EPS $4.02 (+74% YoY); raises FY 2025 EBITDA outlook to $4.40-$4.54B

TENET HEALTHCARE CORP

2025-Q2 EPS reported $7.43 revenue$10,494,000,000

Q2 2025 net income $288M, $3.14 diluted EPS; adjusted diluted EPS $4.02 vs $2.31 in Q2 2024.
Consolidated Adj. EBITDA $1.121B (+18.6% YoY); margin 21.3%. Ambulatory Care Adj. EBITDA $498M (+11.4%).
Board authorized $1.5B increase to share repurchase program, leaving $1.781B remaining as of July 22.
FY 2025 Adj. EBITDA outlook raised to $4.40-$4.54B (midpoint +$395M vs prior). Free cash flow guide $2.025-$2.275B.
H1 2025 free cash flow $1.385B vs $948M in H1 2024; net debt/Adj. EBITDA 2.45x.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.